Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 5/20 | 0.43 |
| ▸ | CCNT1 | O60563 | 4/20 | 0.43 |
| ▸ | CDK1 | P06493 | 3/20 | 0.41 |
| ▸ | CDK4 | P11802 | 3/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 3/20 | 0.41 |
| ▸ | CCND1 | P24385 | 3/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.41 |
| ▸ | CDK2 | P24941 | 3/20 | 0.41 |
| ▸ | CCNA1 | P78396 | 3/20 | 0.41 |
| ▸ | CDK3 | Q00526 | 3/20 | 0.41 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.41 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.41 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.41 |
| ▸ | CDK7 | P50613 | 2/20 | 0.41 |
| ▸ | CCNH | P51946 | 2/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.38 |
| ▸ | BTK | Q06187 | 2/20 | 0.38 |
| ▸ | CCNC | P24863 | 1/20 | 0.37 |
| ▸ | CDK8 | P49336 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558377 | 0.89 | CCNT1 (0.43) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL24418616 | 0.88 | CCNT1 (0.47) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL21877653 | 0.87 | CDK9 (0.48) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL24418662 | 0.85 | CDK9 (0.51) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL29558494 | 0.84 | CDK9 (0.49) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL29558303 | 0.83 | CDK9 (0.46) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL24418615 | 0.81 | CDK9 (0.64) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL21877674 | 0.81 | CDK2 (0.43) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL26871370 | 0.80 | CDK9 (0.52) | CDK9CCNT1CDK1CDK4CCNA2 | |
| SCHEMBL24418649 | 0.80 | CCNT1 (0.46) | CDK9CCNT1CDK1CDK4CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188084-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2025-06-12 | — | — | US | disclosed |
| EP-4240422-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2023-09-13 | — | — | EP | disclosed |
| WO-2022098843-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | Kronos Bio, Inc. (US) | 2022-05-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188084-A1 | COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY | CDK9, CDK19, CDKL1 | CDK9 1/4885CCNT1 86/4885CDK1 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.